Skip to main content
Margaret Koziel, MD, Infectious Disease, Cambridge, MA, UMass Memorial Medical Center

MargaretJKozielMD

Infectious Disease Cambridge, MA

Chief Medical Officer, Axcella Therapeutics

Dr. Koziel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Koziel's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1989 - 1992
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1989
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1985
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterChief Residency, Internal Medicine
  • Massachusetts General Hospital
    Massachusetts General Hospital

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1988 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2006

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Trial Investigating Potential Treatment for Fatigue Relief in People with Long COVID Reports Results
    Trial Investigating Potential Treatment for Fatigue Relief in People with Long COVID Reports ResultsApril 14th, 2023
  • Accelerating Treatments in Long COVID: What Will It Take? The Solve M.E. / BIO Webinar Series
    Accelerating Treatments in Long COVID: What Will It Take? The Solve M.E. / BIO Webinar SeriesMarch 7th, 2023
  • Experimental Long COVID Drug Shows Promise Tackling Fatigue
    Experimental Long COVID Drug Shows Promise Tackling FatigueAugust 5th, 2022
  • Join now to see all

Grant Support

  • Immunologic Correlates Of Liver Disease ProgressionNational Institute Of Allergy And Infectious Diseases2005–2009
  • Determinants Of Liver Injury In Chronic Hepatitis C Virus InfectionNational Institute Of Allergy And Infectious Diseases2007
  • Determinants Of Liver Injury In Chronic HCV InfectionNational Institute Of Allergy And Infectious Diseases2005–2006
  • Natural Killer T Cells In An Animal Model Of Hepatitis CNational Institute Of Allergy And Infectious Diseases2004–2006
  • T Lymphocyte Apoptosis In Hepatitis C PersistenceNational Institute Of Allergy And Infectious Diseases2002–2006
  • Natural Killer T Cells In An Animal Model Of Hepatitis CNational Institute Of Allergy And Infectious Diseases2003
  • Immunity To Hepatitis C In Liver Transplant RecipientsNational Institute Of Allergy And Infectious Diseases1997–2001
  • Cellular Immunity To Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases1996
  • Cellular Immunity To Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases1994–1996
  • Cytotoxic T Lymphocytes In Hepatitis C Virus InfectionNational Institute Of Allergy And Infectious Diseases1991–1992

Hospital Affiliations